This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.



Biocytogen is a premier partner that provides one-stop solution for drug development, from concept to IND application. With cutting-edge technologies, state-of-art animal facility, and world-class platforms for efficient antibody drug development, Biocytogen offers comprehensive in vivo/in vitro preclinical services, animal model generation, antibody fully human RenMabTM mouse model, therapeutic antibody discovery and development, CMC/CDMO, and regulatory affairs support. Biocytogen collaborates with more than 70% of top 50 pharmaceutical and numerous biotech start-up companies worldwide. Together, we discover innovative medicines for a better, healthier world.

We're bringing you

  • RenMabTM Mouse and In Vivo Efficacy-based Solution Empower Fully Human Antibody Drug Discovery